Treating menopause—MHT and beyond

SR Davis, RJ Baber - Nature Reviews Endocrinology, 2022 - nature.com
Every woman who lives past midlife will experience menopause, which, by definition, is
complete cessation of ovarian function. This process might occur spontaneously (natural …

Secondary osteoporosis

PR Ebeling, HH Nguyen, J Aleksova… - Endocrine …, 2022 - academic.oup.com
Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

Landscape of pathogenic mutations in premature ovarian insufficiency

H Ke, S Tang, T Guo, D Hou, X Jiao, S Li, W Luo… - Nature Medicine, 2023 - nature.com
Premature ovarian insufficiency (POI) is a major cause of female infertility due to early loss of
ovarian function. POI is a heterogeneous condition, and its molecular etiology is unclear. To …

[HTML][HTML] Impacts of endocrine disrupting chemicals on reproduction in wildlife and humans

VL Marlatt, S Bayen, D Castaneda-Cortès… - Environmental …, 2022 - Elsevier
Endocrine disrupting chemicals (EDCs) are ubiquitous in aquatic and terrestrial
environments. The main objective of this review was to summarize the current knowledge of …

Primary ovarian insufficiency

CA Stuenkel, A Gompel - New England Journal of Medicine, 2023 - Mass Medical Soc
Key Clinical Points Primary Ovarian Insufficiency Primary ovarian insufficiency should be
considered in women younger than 40 years of age who present with new-onset irregular …

The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis

M Li, Y Zhu, J Wei, L Chen, S Chen, D Lai - Climacteric, 2023 - Taylor & Francis
Objective The objective of this review was to answer the global prevalence of premature
ovarian insufficiency (POI), and explore the associated factors including etiopathology and …

Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review

SM Nelson, SR Davis, S Kalantaridou… - Human …, 2023 - academic.oup.com
BACKGROUND The early onset of menopause is associated with increased risks of
cardiovascular disease and osteoporosis. As a woman's circulating anti-Müllerian hormone …

Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data

D Zhu, HF Chung, AJ Dobson, N Pandeya… - The Lancet Public …, 2019 - thelancet.com
Background Early menopause is linked to an increased risk of cardiovascular disease
mortality; however, the association between early menopause and incidence and timing of …

Management of menopause: a view towards prevention

RA Lobo, A Gompel - The Lancet Diabetes & Endocrinology, 2022 - thelancet.com
Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …

Premature ovarian insufficiency: an international menopause society white paper

N Panay, RA Anderson, RE Nappi, AJ Vincent… - …, 2020 - Taylor & Francis
The aim of this International Menopause Society White Paper on premature ovarian
insufficiency (POI) is to provide the latest information regarding this distressing condition …